Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Personal BP - CAI Study

NCT: NCT06492746 · RECRUITING

NCT IDNCT06492746
StatusRECRUITING
Start Date2024-06-03
Completion2027-01
SponsorBecton, Dickinson and Company (INDUSTRY)
First posted
Last updated

Brief Summary

A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets

Frequently Asked Questions

What is Personal BP - CAI Study?

Personal BP - CAI Study is a clinical trial registered under NCT06492746. Current status: RECRUITING.

What is the status of NCT06492746?

The current status of NCT06492746 (Personal BP - CAI Study) is: RECRUITING.

When did Personal BP - CAI Study start?

Personal BP - CAI Study started on 2024-06-03.

Related Devices

K151320BD Phoenix Automated Microbiology System-Ertapenem 0.0625-8 mcg/mlBecton, Dickinson and Company K151589BD MAX CT/GC/TV, BD MAX INSTRUMENTBecton, Dickinson and Company K151866BD BACTEC Peds Plus/F Culture Vials (plastic)Becton, Dickinson and Company K151870BD U-500 INSULIN SYRINGEBecton, Dickinson and Company K153309BD Vacutainer UltraTouch Push Button Blood Collection SetBecton, Dickinson and Company

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑